Literature DB >> 25715231

The Work Activity and Participation Outcomes Framework: a new look at work disability outcomes through the lens of the ICF.

Rawan A AlHeresh1, Julie J Keysor.   

Abstract

Work disability is common among people with chronic conditions. The terminology in the field is variable and often used interchangeably and there is a lack of comprehensive frameworks to describe work as an outcome. Varied operationalization of work disability makes it difficult to establish precise estimates of the impact of chronic musculoskeletal conditions on work. A new conceptual framework was developed using the International Classification of Functioning, Disability and Health and was named 'Work Activity and Participation Outcome (Work APO) Framework' which clarified definitions in the field. Applying the framework to people at risk of work disability and evaluating their outcomes could advance the literature.

Entities:  

Mesh:

Year:  2015        PMID: 25715231     DOI: 10.1097/MRR.0000000000000112

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  3 in total

Review 1.  Critical Appraisal of the Quality of Literature Evaluating Psychometric Properties of Arthritis Work Outcome Assessments: A Systematic Review.

Authors:  Rawan Alheresh; Molly Vaughan; Michael P LaValley; Wendy Coster; Julie J Keysor
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-27       Impact factor: 4.794

2.  Construct Validity and Scoring Methods of the World Health Organization: Health and Work Performance Questionnaire Among Workers With Arthritis and Rheumatological Conditions.

Authors:  Rawan AlHeresh; Michael P LaValley; Wendy Coster; Julie J Keysor
Journal:  J Occup Environ Med       Date:  2017-06       Impact factor: 2.162

3.  Cost-effectiveness of 40-hour versus 100-hour vocational rehabilitation on work participation for workers on sick leave due to subacute or chronic musculoskeletal pain: study protocol for a randomized controlled trial.

Authors:  Timo T Beemster; Judith M van Velzen; Coen A M van Bennekom; Monique H W Frings-Dresen; Michiel F Reneman
Journal:  Trials       Date:  2015-07-28       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.